About the company
Ocugen Inc is at the forefront of the biopharmaceutical industry, dedicated to transforming the lives of individuals suffering from various forms of blindness. With a strong focus on discovering, developing, and commercializing gene therapies, this clinical-stage company is paving the way for groundbreaking treatments that hold the promise of curing previously incurable diseases. One of the key pillars of Ocugen's research and development efforts lies in their innovative gene therapy platform. This platform is designed to combat a wide range of retinal diseases with a single drug, offering a potential one-to-many treatment approach. By targeting the underlying genetic causes of these diseases, Ocugen is aiming to revolutionize the way blindness is treated, providing new hope and improved quality of life for countless patients. Among the diseases in Ocugen's sights are wet age-related macular degeneration (AMD), diabetic macular edema (DME), and diabetic retinopathy. These conditions, which often result in severe vision loss or blindness, currently have limited treatment options. Ocugen's novel biologic product candidate aims to address this underserved patient population, offering more effective therapies that can potentially halt or reverse the progression of these debilitating diseases. In addition to their focus on ocular gene therapies, Ocugen has also taken on the global battle against COVID-19. The company is actively co-developing Bharat Biotech's COVAXIN vaccine candidate for COVID-19 in the United States and Canadian markets. As the pandemic continues to impact millions of lives worldwide, Ocugen recognizes the urgent need for effective vaccines, and their collaboration with Bharat Biotech exemplifies their commitment to saving lives and ensuring global public health. With their dedication to pioneering gene therapies and their contribution to the fight against COVID-19, Ocugen Inc is making significant strides in the field of biopharmaceuticals. Their innovative approach, coupled with their commitment to improving patient outcomes, has positioned them as leaders in the pursuit of novel treatments for blindness and infectious diseases. As they continue to advance their research and development efforts, Ocugen is poised to make a lasting impact on the lives of countless individuals around the world.
Website: https://www.ocugen.com
Data updated: June 2, 2026
